Clinical trial

Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes

NCT01223196

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-08-01

PhasePHASE4

Study timeline

Study start (unknown)2009-08-01Date precision: month

Registry last updated2016-01-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

PioglitazoneDRUG · verified · RxNorm: pioglitazone

PlaceboDRUG

Sponsors & collaborators

The University of Texas Health Science Center at San Antoniolead sponsor

Mapped research locations

San AntonioTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01223196 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.